Kaletra

Victory! Colombian Government Cuts Price of Abbott's Lifesaving AIDS Drug Kaletra 55%, Says AHF

Advocates Claim Victory as Government Cuts & Freezes Price at $1,067 USD for Public Institutions and $1,591 USD for Hospitals, Clinics & Private Sector--55% Less than Abbott's Previous Colombian Price Since January, Colombian, Mexican & US AIDS Advocates Protested Steep Price of ...

AIDS Foundation Lauds Brazil for Negotiating Price Cut on Abbott's Kaletra

AIDS Healthcare Foundation (AHF), the US' largest HIV/AIDS healthcare, prevention and education provider, which operates free AIDS treatment clinics in the US, Africa, Latin America/Caribbean and Asia, today lauded the government of Brazil for successfully negotiating a price cut of 30% on Abbott ...

Abbott Reports Strong Second Quarter Results; Confirms Double-Digit Earnings Growth Outlook for 2009

...20.9 $676 44.0 (24.0) 20.0 kaletra $111 (8.0) $232 13.9 (15... $1,311 32.8 (12.4) 20.4 kaletra $343 6.5 (10.0...12.7 $1,290 46.4 (22.3) 24.1 kaletra $195 (16.3) $440 6.1 (13...

Abbott Reports 16 Percent Earnings Growth in First Quarter; Confirms Double-Digit Earnings Growth Outlook for 2009

...UMIRA $410 2.0 $614 29.0 $1,024 16.7 kaletra $85 (25.1) $207 (13.6) $292 (17.3) TriCo...IRA $614 49.4 (20.4) 29.0 kaletra $207 (1.5) (12.1) (13.6) Lup...

Abbott Reports Double-Digit Sales and Earnings Growth in Fourth Quarter; Confirms Strong Outlook for 2009 Earnings

... 16.0 --- --- $455 16.0 kaletra $152 (0.7) $226 3.5 b ...ut the negative impact of exchange of 4.9 percent, kaletra sales increased 8.4 percent internationally.... 36.6 $2,266 60.4 a $4,521 47.6 kaletra $513 (4.7) $961 22.1 b ...

Abbott Releases 2007 Global Citizenship Report Highlighting Strong Commitment to Access to Health Care

...HIV. The tablet does not require refrigeration and does not need to be taken with food -- two important advances in delivering HIV medicine. kaletra (known as Aluvia in developing countries) was filed or has been approved in 156 developed and developing countries. Science Education -- S...

Abbott Reports Double-Digit Sales and Earnings Growth in First Quarter and Reaffirms Full-Year Growth Outlook

... $341 11.7 $24 12.2 $365 11.7 kaletra $113 (3.2) $240 31.2 (b) ...t the positive impact of exchange of 10.5 percent, kaletra sales increased 20.7 percent internationally.... continued strength of the international launch of kaletra tablets. U.S. pharmaceutical sales growth ...

Abbott's Kaletra(R) and Aluvia(R) (lopinavir/ritonavir) New Lower-Strength Tablet for Pediatric Use Receives Positive Opinion from EMEA

...for marketing authorization for the lower-strength kaletra in the European Union within the next 60-90 days. ... for the initial treatment of children with HIV. kaletra Lower-Strength Tablets The new tablet formulation will complement kaletra oral solution, which has been available for pediat...

Ugandan Children Are Among the First to Receive Abbott's Lower-Strength Aluvia (lopinavir/ritonavir) Tablet

...Web site at http://www.abbott.com/hiv . About kaletra Indication and Important Safety Information for lopinavir/ritonavir Indication kaletra is indicated for the treatment of HIV-1 infected a...in combination with other antiretroviral agents. kaletra does not cure HIV infection or AIDS and does not r...

Abbott Receives U.S. Food and Drug Administration Approval for New Lower-Strength Kaletra(R) (lopinavir/ritonavir) Tablet for Pediatric HIV Patients

...navir) in developing countries. The lower-strength kaletra tablets will be available in the U.S. this month. ...this formulation. Approval of this lower-strength kaletra tablet represents an important step in Abbott's on...gth tablets are smaller in size than original kaletra tablets and contain the same proven active ingredi...

Kaletra in Medical Technology

New Phase 3 Study Published in The Lancet Evaluates Efficacy and Safety of Prezista/Ritonavir vs. Kaletra as Part of HIV Combination Therapy in Treatment-Experienced Adults With HIV

BRIDGEWATER, N.J., July 05, 2007 /PRNewswire/ -- Results from the primary analysis of a randomized, controlled, open-label, Phase 3 study showed that 77 percent of treatment-experienced HIV-1 infected adults taking PREZISTA(TM) (darunavir) 600 mg tablets with 100 mg ritonavir (PREZISTA/r) twice da...

Abbott's Kaletra(R) Tablet Dosed Once-Daily or Twice-Daily Demonstrated Similar Clinical Results Across Race and Gender Lines

... results showed that regardless of gender or race, kaletra dosed once-daily or twice-daily as part of a treat...search and Development, Abbott. "Additionally, the kaletra tablet formulation is a convenient HIV treatment o...ww.abbott.com/hiv . About Kaletra Indication kaletra (lopinavir/ritonavir) is a human immunodeficiency ...

Kaletra in Biological Technology

Abbott vs. Thailand has implications for innovation and access

...wing the Abbott Laboratories story regarding its kaletra AIDS drug and the conflict with the government of ...d so far: Fall 2006: Abbott lowers the price of kaletra sold in Thailand from $2,200 per year to $1,700. ... the Thai market, including the new formulation of kaletra (called Aluvia). This move sparks protests in Thai...